Cited by 500Biosensors and Analytical DetectionClinical Laboratory Practices and Quality ControlBacterial Identification and Susceptibility Testing

Point-of-care tests for diagnosing infections in the developing world

Open access
Peeling, R.W., Mabey, D.·2010·Clinical Microbiology and Infection

Abstract

Infectious diseases continue to cause an enormous burden of death and disability in developing countries. Increasing access to appropriate treatment for infectious diseases could have a major impact on disease burden. Some common infections can be managed syndromically without the need for diagnostic tests, but this is not appropriate for many infectious diseases, in which a positive diagnostic test is needed before treatment can be given. Since many people in developing countries do not have access to laboratory services, diagnosis depends on the availability of point of care (POC) tests. Historically there has been little investment in POC tests for diseases that are common in developing countries, but that is now changing. Lack of regulation of diagnostic tests in many countries has resulted in the widespread use of sub-standard POC tests, especially for malaria, making it difficult for manufacturers of reliable POC tests to compete. In recent years increased investment, technological advances, and greater awareness about the importance of reliable diagnostic tests has resulted in rapid progress. Rapid, reliable and affordable POC tests, requiring no equipment and minimal training, are now available for HIV infection, syphilis and malaria, but POC tests for other infections are urgently needed. Many countries do not have established criteria for licensing and introducing new diagnostic tests, and many clinicians in developing countries have become disillusioned with diagnostic tests and prefer to rely on clinical judgment. Continuing advocacy and training in the use of POC tests are needed, and systems for quality control of POC tests need to be developed if they are to achieve their maximum potential.

Integrity signals

Registry

Crossref · 10.1111/j.1469-0691.2010.03279.x

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Distance to care, lack of connectivity, and poor laboratory infrastructure in many resource-poor areas preclude widespread adoption of resource-heavy diagnostic techniques such as skin biopsy reads by dermatopathologists.

    “Distance to care, lack of connectivity, and poor laboratory infrastructure in many resource-poor areas precludes the widespread adoption of resource-heavy diagnostic techniques, such as skin biopsy reads by dermatopathologists”

    From Global Burden of Skin Disease: Inequities and Innovations (2017) · cites this paper as [42]

Cites

Flagged first, then by citations

3 of the 56 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Peeling, R. W., & Mabey, D.
Affiliations
London School of Hygiene & Tropical Medicine (GB)
Corresponding author
Peeling, R.W.
Venue
Clinical Microbiology and Infection
Publisher
Elsevier BV
Published
2010-08
Volume
16
Issue
8
Pages
1062-1069
ISSN
1198-743X (ISSN-L)
OpenAlex
W1748737970
Cited by
500
References
56
Citations by year
2026: 31 · 2025: 19 · 2024: 30 · 2023: 20 · 2022: 23 · 2021: 27 · 2020: 45 · 2019: 37 · 2018: 47 · 2017: 36 · 2016: 44 · 2015: 45 · 2014: 29 · 2013: 32 · 2012: 18
FWCI
1.73
Type
journal article
Language
en
Open access
Locations
  • Clinical Microbiology and Infection (publishedVersion)
  • PubMed (publishedVersion)
Funders
Wellcome Trust
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
  • Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Bacterial Identification and Susceptibility Testing
Keywords
point-of-care testing, infectious disease diagnosis, developing countries, malaria diagnosis, HIV testing, syphilis testing, diagnostic test regulation, syndromic management
MeSH terms
Developing Countries, Education, Medical, Continuing, Humans, Malaria, Quality Control, Syphilis, HIV Infections, Point-of-Care Systems, Molecular Diagnostic Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review